Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01139957 · ClinicalTrials.gov registry record

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

A clinical trial of Breast Carcinoma and Primary Peritoneal Carcinoma, sponsored by Gynecologic Oncology Group.

Completed
Registry status
1,916
Enrollment target
20
Study locations

NCT01139957 is a study of Breast Carcinoma and Primary Peritoneal Carcinoma that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 1,916 participants, above the 752-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (155% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01139957, a study of Breast Carcinoma and Primary Peritoneal Carcinoma, has completed, sponsored by Gynecologic Oncology Group.

COMPLETED
Registry status
1,916 participants
Enrollment target
20
Study locations

Study Summary

This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and on-going care.

Conditions Studied

Breast Carcinoma Primary Peritoneal Carcinoma Fallopian Tube Carcinoma Ovarian Neoplasm

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • PROCEDURE Evaluation of Cancer Risk Factors
  • PROCEDURE Study of High Risk Factors

Study Locations (20)

Connecticut

  • Hartford Hospital - Hartford
  • Smilow Cancer Hospital Care Center at Saint Francis - Hartford
  • The Hospital of Central Connecticut - New Britain
  • Yale University - New Haven

Florida

  • Florida Gynecologic Oncology - Fort Myers
  • Mayo Clinic in Florida - Jacksonville
  • Sarasota Memorial Hospital - Sarasota
  • Women's Cancer Associates - St. Petersburg

Illinois

  • Rush University Medical Center - Chicago
  • University of Chicago Comprehensive Cancer Center - Chicago
  • NorthShore University HealthSystem-Evanston Hospital - Evanston

Arizona

  • Gynecologic Oncology Group of Arizona - Phoenix
  • Mayo Clinic in Arizona - Scottsdale

Delaware

  • Beebe Medical Center - Lewes
  • Christiana Care Health System-Christiana Hospital - Newark

Alabama

  • University of Alabama at Birmingham Cancer Center - Birmingham

California

  • UCLA / Jonsson Comprehensive Cancer Center - Los Angeles

Colorado

  • University of Colorado Hospital - Aurora

Trial Details

FieldValue
Enrollment Target 1,916 participants
Start Date 2010-06-07
Est. Completion 2020-04-10

Sponsor

Gynecologic Oncology Group

154 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01139957

The ClinicalTrials.gov registry entry for NCT01139957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,916 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 752-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (155% higher). The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT01139957 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Connecticut, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT01139957 about?

NCT01139957 is a clinical study titled "Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer". This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and...

What is the current status of trial NCT01139957?

This trial is currently completed. The enrollment target is 1,916 participants. The study started on 2010-06-07. Estimated completion is 2020-04-10.

What conditions does trial NCT01139957 study?

This clinical trial studies the following conditions: Breast Carcinoma, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma, Ovarian Neoplasm.

What interventions are being tested in trial NCT01139957?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Evaluation of Cancer Risk Factors (PROCEDURE), Study of High Risk Factors (PROCEDURE).

Who is sponsoring clinical trial NCT01139957?

This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01139957 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Carcinoma

All registered trials for this condition

Primary Peritoneal Carcinoma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.